Related Experiment Video
Updated: Aug 13, 2026
08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Cyclophosphamide-like cellular immunostimulation induced by 6-thioguanine (Lanvis)
Immunology
|June 1, 1978
Summary
The drug 6-thioguanine can suppress immune responses when given shortly before immunization. However, delaying administration of 6-thioguanine can enhance immune reactions, particularly delayed hypersensitivity.
Area of Science:
- Immunology
- Pharmacology
Background:
- The immunomodulatory effects of thiopurines are complex.
- 6-thioguanine is an antimetabolite with potential immune-altering properties.
Purpose of the Study:
- To investigate the potential immunostimulating effects of 6-thioguanine.
- To determine the influence of administration timing on 6-thioguanine's immunomodulatory activity.
Main Methods:
- Mice were treated with varying doses of 6-thioguanine.
- Immunization was performed at different intervals (1 day vs. 5 days) post-drug administration.
- Cellular and humoral immune responses, including delayed hypersensitivity, were assessed.
Main Results:
- 6-thioguanine caused dose-dependent suppression of immune responses when given 1 day before immunization.
- A significant enhancement of delayed hypersensitivity was observed when 6-thioguanine was administered 5 days prior to immunization.
- This enhancement was specific to certain immunization doses (10(6) and 10(7) sheep red cells).
Conclusions:
- The timing of 6-thioguanine administration critically influences its effect on the immune system.
- Delayed administration of 6-thioguanine can lead to immunostimulation, specifically enhancing delayed hypersensitivity.
- These findings suggest a potential therapeutic window for 6-thioguanine as an immunomodulator, similar to cyclophosphamide.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...